miR-877-3p inhibits tumor growth and angiogenesis of osteosarcoma through Fibroblast Growth Factor 2 signaling

Osteosarcoma (OS) is the most common high-grade malignant bone tumor in teenagers. MicroRNAs can function as post-transcriptional regulators of gene expression, playing critical roles in cancer development and metastasis. Our study aims to investigate the role and underlying molecular mechanism of m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hailin Zhou, Lei Cao, Cheng Wang, Chi Fang, HaiHui Wu, Chao Liu
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/ce8dd4746e864a98a24cad4a153d214b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Osteosarcoma (OS) is the most common high-grade malignant bone tumor in teenagers. MicroRNAs can function as post-transcriptional regulators of gene expression, playing critical roles in cancer development and metastasis. Our study aims to investigate the role and underlying molecular mechanism of miR-877-3p in OS. Quantitative real-time RT-PCR was carried out for detecting miR-877-3p expression in OS. The effects of miR-877-3p on proliferation was analyzed via MTT, colony formation and flow cytometry assays. Angiogenesis of endothelial cells were investigated by wound healing and tube formation assay. Gene profiling based on PCR array and luciferase reporter assay were conducted to determine target genes of miR-877-3p. In-vivo study was used to determine the effects of miR-877-3p on the tumor growth. The expression of miR-877-3p was markedly down-regulated in OS tissues and cell lines. Low expression of miR-877-3p predicts poor prognosis of OS patients. miR877-3p overexpression was found to inhibit the proliferation of OS cell lines. The angiogenesis assays showed that miR-877-3p attenuated the angiogenesis. Further mechanism studies showed that miR-877-3p can reduce (Fibroblast Growth Factor 2) FGF2 expression in OS cells by binding to the 3ʹUTR end of FGF2. Moreover, increased expression of miR-877-3p was responsible for the inhibition of tumor growth and angiogenesis. Taken together, our findings indicated that miR-877-3p might exhibit tumor suppressive role by targeting FGF2 signaling, which may serve as potential target for OS.